Login
$ARDX
$3.00 +$0.00 (0.0%) Close

Company Executives

$ARDX Management Team

Mr. David Mott

Independent Chairman of the Board

Age 59
Compensation $310.0K USD
Sex Male

Mr. Michael Raab

President

Chief Executive Officer

Director

Age 60
Compensation $9.606M USD
Sex Male

Mr. James Brady

Chief Human Resources Officer

Age -
Compensation -
Sex Male

Ms. Elizabeth Grammer

Chief Legal and Administrative Officer

Age 61
Compensation $2.973M USD
Sex Female

Mr. Eric Foster

Chief Commercial Officer

Age 50
Compensation -
Sex Male

Mr. Mike Kelliher

Chief Business Officer

Age 48
Compensation $2.991M USD
Sex Male

Dr. Laura Williams

Interim Chief Medical Officer

Age 62
Compensation $2.827M USD
Sex Female

Ms. Sue Hohenleitner

Chief Financial Officer

Age 55
Compensation -
Sex Female

Dr. Edward Conner

Chief Medical Officer

Age -
Compensation -
Sex Male
Directors
8
serving now
Independent
0 of 1
stated in the proxy; 7 not stated
Average tenure
10.0 years
from year joined
CEO also chairs the board
No
David Mott
Director Age On board Independent Committees Other public boards 2025 pay Source
Robert Bazemore
58 2016
10 years
Not stated None stated Nuvation Bio, Inc. $356,886
Muna Bhanji
63 2021
5 years
Not stated
Nominating and Corporate Governance Committee
Veracyte, Inc. Not stated
Richard Rodgers
59 2014
12 years
Not stated None stated Novavax, Inc. $376,886
William Bertrand, Jr., Esq.
61 2015
11 years
Not stated None stated None stated $369,386
Onaiza Cadoret-Manier
62 2020
6 years
Not stated None stated None stated $354,386
Merdad Parsey, M.D., Ph.D.
63 2025
1 year
Not stated
Nominating and Corporate Governance Committee
Arrivent Biopharma $503,349
David Mott
60 2009
17 years
Not stated
Audit and Compliance Committee
Novavax, Inc. $411,886
Michael Raab
61 2008
18 years
Not independent None stated Tempest Therapeutics Paid as CEO

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

1 disclosed in the proxy filed Apr 29, 2026
each of our directors and executive officers
Amount not stated

Indemnification agreements requiring the company to indemnify each director and executive officer to the fullest extent permitted by Delaware law, including expenses, judgments, penalties, fines and settlements.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support